Adjuvant pulse-dose-rate brachytherapy for oral cavity and oropharynx carcinoma: Outcome and toxicity assessment of 66 patients

CONCLUSIONS: Oral and oropharyngeal PDR-BT as adjuvant treatment is safe and effective for well-defined indications.PMID:38584888 | PMC:PMC10993891 | DOI:10.5114/jcb.2024.135626

Source: Journal of Contemporary Brachytherapy - April 8, 2024 Category: Cancer & Oncology Authors: Sophie Renard Nicolas Demogeot Marie Bruand Nassim Sahki Vincent Marchesi William Gehin Emilie Meknaci Didier Peiffert Source Type: research